Merck Hit With Patent Suit Over Cancer Drug Keytruda
PDL BioPharma Inc. blasted Merck Sharp & Dohme Corp. over cancer drug Keytruda in New Jersey federal court Monday, alleging the medication infringes on the company's patent related to a type...To view the full article, register now.
Already a subscriber? Click here to view full article